Metastic Thyroid Cancer

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Metastic Thyroid Cancer trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT04927416

The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer

Background: About 5% to 10% of differentiated thyroid cancers become resistant to standard treatment with radioactive iodine. In these cases, treatment options…

United States54 participantsStarted 2021-10-25

Treatment: 68-Gallium-DOTATATE-PET/CT

Metastic Thyroid Cancer

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer

All recent trials (1 shown)